Navamedic ASA
Research Navamedic ASA (NAVA) on Bullrun: market cap NOK 357.32M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNAVA
- ExchangeOL
- CountryNorway
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyNOK
- Market capNOK 357.32M
- Financial periodQ1 2026
- RevenueNOK 137.90M
- Net income-NOK 120.00K
- Free cash flowNOK 760.00K
- Gross margin39.5%
Valuation Snapshot
latest market cap is NOK 357.32M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | NOK 565.36M | -NOK 23.54M | NOK 23.20M | 38.5% | -1.24 | NOK 74.16M | NOK 208.22M | NOK 334.08M |
| FY2024 | NOK 531.44M | -NOK 5.49M | NOK 36.03M | 38.7% | -0.31 | NOK 37.29M | NOK 118.57M | NOK 216.67M |
| FY2023 | NOK 512.00M | -NOK 13.69M | -NOK 20.00K | 38.7% | -0.79 | NOK 38.04M | NOK 152.89M | NOK 205.40M |
| FY2022 | NOK 382.14M | NOK 29.43M | NOK 15.69M | 42.8% | 1.73 | NOK 55.30M | NOK 58.72M | NOK 209.72M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | NOK 357.32M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 NOK.
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Navamedic ASA's market cap?
Navamedic ASA's market capitalization is NOK 357.32M.
What does Navamedic ASA do?
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics.